Eye care delivery company spun off from parent; RNAi lawsuit thrown out;

> U.K. drug delivery specialist Q Chop spun off a new eye company called OpsiRx Pharmaceuticals, focused on the delivery of long-lasting products administered directly to the eye using minimally invasive needles. Release

> An intellectual property lawsuit related to the discovery of RNA interference brought against Carnegie Institution of Washington by a UMass researcher was thrown out of a U.S. District Court on a technicality. More (sub. req.)

> Liquidia Technologies formed a new oral health company, Lq3 Pharmaceuticals. The new Morrisville, NC-based company will use Liquidia's Particle Replication in Non-Wetting Templates nanoparticle development platform. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.